Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial

Authors

Institutions

Publication Details

Journal
International Journal of Gynecological Cancer
Published
2026-01-01
DOI
https://doi.org/10.1016/j.ijgc.2025.104456
Primary Topic
Cancer Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial

Aliona Filimonava, Olga Streltsova, Y. Baranau, S. Polyakov et al.
International Journal of Gynecological Cancer
Cancer Research and Treatments
article

Elenagen, a p62/SQSTM1-encoding plasmid, improves overall survival in patients with platinum-resistant ovarian cancer: a phase II trial

Aliona Filimonava, Olga Streltsova, Y. Baranau, S. Polyakov, Alexander Shneider, Vladimir L. Gabai, S. А. Krasny, Ekaterina Zharkova, Gabriel Levin, Evgeny Bakin
article en

Abstract

No abstract available for this paper.
International Journal of Gynecological Cancer
ORT Israel (IL), McGill University Health Centre (CA), AVEO Oncology (United States) (US), 9th City Clinical Hospital (BY), N.N. Alexandrov National Cancer Centre (BY), McGill University (CA), Ariel University (IL)
Zero hunger
Openalex Percentile: Top 94%
Cancer Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.